Stoke Therapeutics, Inc.
STOK · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$89 | -$105 | -$101 | -$86 |
| Dep. & Amort. | $2 | $2 | $2 | $1 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $27 | $25 | $23 | $16 |
| Change in WC | -$28 | -$6 | $43 | $0 |
| Other Non-Cash | $1 | $2 | $2 | $1 |
| Operating Cash Flow | -$87 | -$81 | -$32 | -$67 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$2 | -$4 | -$1 |
| Net Acquisitions | $0 | $0 | $45 | $75 |
| Inv. Purchases | -$167 | $0 | -$201 | -$87 |
| Inv. Sales/Matur. | $60 | $108 | $159 | $12 |
| Other Inv. Act. | $0 | $0 | -$45 | -$75 |
| Investing Cash Flow | -$107 | $106 | -$46 | -$76 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $129 | $52 | $45 | $1 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $2 | $1 | $1 | -$0 |
| Financing Cash Flow | $131 | $53 | $46 | $1 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$63 | $78 | -$31 | -$142 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $192 | $114 | $145 | $288 |
| End Cash | $129 | $192 | $114 | $145 |
| Free Cash Flow | -$87 | -$83 | -$36 | -$68 |